Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 57

1.

Turning the criticism into construction.

Clay PG.

J Am Pharm Assoc (2003). 2016 Sep-Oct;56(5):599-600. doi: 10.1016/j.japh.2016.08.001. No abstract available.

PMID:
27594112
2.

Pharmacist extenders: An emerging way to deliver care.

Clay PG.

J Am Pharm Assoc (2003). 2016 Jul-Aug;56(4):479-80. doi: 10.1016/j.japh.2016.06.009. No abstract available.

PMID:
27450144
3.

"Pitching" pharmacists as improvers of transition-of-care outcomes.

Clay PG.

J Am Pharm Assoc (2003). 2016 May-Jun;56(3):348. doi: 10.1016/j.japh.2016.04.558. No abstract available.

PMID:
27156945
4.

Community pharmacists as diabetic complication preventers?

Clay PG.

J Am Pharm Assoc (2003). 2016 Mar-Apr;56(2):216. doi: 10.1016/j.japh.2016.02.002. No abstract available.

PMID:
27000175
5.

Pharmacists entering "a brave new world".

Clay PG.

J Am Pharm Assoc (2003). 2016 Jan;56(1):104. doi: 10.1016/j.japh.2015.12.002. No abstract available.

PMID:
26802930
6.

Trying to bring common sense to the Common Rule1.

Clay PG.

J Am Pharm Assoc (2003). 2015 Nov-Dec;55(6):680. doi: 10.1331/JAPhA.2015.15552. No abstract available.

PMID:
26547603
7.

Adherence, Healthcare Resource Use (Hru) And Costs: A Comparison Of Single-Tablet Regimen (Str) Versus Multi-Tablet Regimen (Mtr) Containing Fixed Dose Combination (Fdc) Regimens.

Narayanan S, Clay PG.

Value Health. 2015 Nov;18(7):A577. doi: 10.1016/j.jval.2015.09.1918. Epub 2015 Oct 20. No abstract available.

PMID:
26533241
8.

Meta-Analysis of Studies Comparing Single and Multi-Tablet Fixed Dose Combination HIV Treatment Regimens.

Clay PG, Nag S, Graham CM, Narayanan S.

Medicine (Baltimore). 2015 Oct;94(42):e1677. doi: 10.1097/MD.0000000000001677.

9.

'In God we trust; all others bring data'.

Clay PG.

J Am Pharm Assoc (2003). 2015 Sep-Oct;55(5):568. doi: 10.1331/JAPhA.2015.15538. No abstract available.

PMID:
26359967
10.

Knowing it and proving it are two different things.

Clay PG.

J Am Pharm Assoc (2003). 2015 Jul-Aug;55(4):464. doi: 10.1331/JAPhA.2015.15524. No abstract available.

PMID:
26161492
11.

Caring for the boomers.

Clay PG.

J Am Pharm Assoc (2003). 2015 May-Jun;55(3):336. doi: 10.1331/JAPhA.2015.15519. No abstract available.

PMID:
26003164
12.

Transitions of care programs with pharmacists continue to demonstrate benefit.

Clay PG.

J Am Pharm Assoc (2003). 2015 Mar-Apr;55(2):224. doi: 10.1331/JAPhA.2015.15513. No abstract available.

PMID:
25749268
13.

Medication therapy management: primum non nocere.

Clay PG.

J Am Pharm Assoc (2003). 2015 Jan-Feb;55(1):112. doi: 10.1331/JAPhA.2015.15505. No abstract available.

PMID:
25575155
14.

Noninfectious Diarrhea in HIV Seropositive Individuals: a Review of Prevalence Rates, Etiology, and Management in the Era of Combination Antiretroviral Therapy.

Clay PG, Crutchley RD.

Infect Dis Ther. 2014 Dec;3(2):103-22. doi: 10.1007/s40121-014-0047-5. Epub 2014 Nov 12. Review.

15.

Medication regimen complexity indices: a tool to focus MTM efforts?

Clay PG.

J Am Pharm Assoc (2003). 2014 Nov-Dec;54(6):664. doi: 10.1331/JAPhA.2014.14542. No abstract available.

PMID:
25379986
16.

Community pharmacies as practice-based research network sites: models of success.

Clay PG.

J Am Pharm Assoc (2003). 2014 Sep-Oct;54(5):568. doi: 10.1331/JAPhA.2014.14534. No abstract available.

PMID:
25216889
17.

How can 'we' make health care better?

Clay PG.

J Am Pharm Assoc (2003). 2014 Jul-Aug;54(4):456. doi: 10.1331/JAPhA.2014.14528. No abstract available.

PMID:
25063268
18.

Using pharmacists to improve outcomes: perceived versus proven results.

Clay PG.

J Am Pharm Assoc (2003). 2014 May-Jun;54(3):320. doi: 10.1331/JAPhA.2014.14518. No abstract available.

PMID:
24816360
19.

Community pharmacists preventing hospital readmissions.

Clay PG.

J Am Pharm Assoc (2003). 2014 Mar-Apr;54(2):208. doi: 10.1331/JAPhA.2014.14514. No abstract available.

PMID:
24632935
20.

Efficacy and safety of crofelemer for noninfectious diarrhea in HIV-seropositive individuals (ADVENT trial): a randomized, double-blind, placebo-controlled, two-stage study.

Macarthur RD, Hawkins TN, Brown SJ, Lamarca A, Clay PG, Barrett AC, Bortey E, Paterson C, Golden PL, Forbes WP.

HIV Clin Trials. 2013 Nov-Dec;14(6):261-73. doi: 10.1310/hct1406-261.

PMID:
24334179
Items per page

Supplemental Content

Loading ...
Write to the Help Desk